| Drug interactions | 37 | May 7, 2012 |
| dietary sources | 13 | April 17, 2012 |
| deficiency | 13 | April 17, 2012 |
| signs and symptoms of deficiency | 49 | April 17, 2012 |
| Vitamins | 16 | April 16, 2012 |
| formulary management | 24 | April 2, 2012 |
| newsletters | 10 | April 2, 2012 |
| Ga State Board of Pharmacy | 70 | March 27, 2012 |
| Federal and State | 5 | March 27, 2012 |
| controlled substances | 74 | March 27, 2012 |
| communication styles | 29 | March 22, 2012 |
| building consensus | 26 | March 22, 2012 |
| resolution of conflict tactics | 13 | March 22, 2012 |
| innovation | 21 | March 22, 2012 |
| Law: Acts | 40 | February 20, 2012 |
| pediatric drug info | 49 | February 12, 2012 |
| personal finance--saving | 60 | February 9, 2012 |
| personal finance | 26 | February 9, 2012 |
| financial performance measures | 62 | February 9, 2012 |
| basics of accounting | 49 | February 9, 2012 |
| 1st set of management notes | 15 | February 9, 2012 |
| drowsiness and fatigue | 33 | February 5, 2012 |
| sleep disorders | 53 | February 5, 2012 |
| intraabdominal | 17 | February 2, 2012 |
| HIV drugs continued | 13 | February 1, 2012 |
| Protease inhibitors continued | 32 | January 31, 2012 |
| protease inhibitor ADRs | 17 | January 31, 2012 |
| NNRSI MSC | 23 | January 30, 2012 |
| NNRTIs (brand/generic) | 7 | January 30, 2012 |
| NRTI adverse effects | 24 | January 30, 2012 |
| NRTIs | 13 | January 30, 2012 |
| osteomyelitis | 15 | January 29, 2012 |
| meningitis | 23 | January 29, 2012 |
| CML (chronic myelogenous leukemia) | 51 | October 26, 2011 |
| colorectal cancer | 65 | October 26, 2011 |
| bladder cancer | 17 | October 26, 2011 |
| renal cancer | 65 | October 26, 2011 |
| breast cancer | 69 | October 26, 2011 |
| toxicity | 82 | October 24, 2011 |
| new interactions | 19 | October 24, 2011 |
| interactions | 73 | October 24, 2011 |
| toxicity | 11 | October 24, 2011 |
| interaction | 12 | October 24, 2011 |
| drug interactions | 26 | October 22, 2011 |
| digoxin distribution | 8 | October 20, 2011 |
| drugs which affect oral digoxin absorption | 8 | October 20, 2011 |
| digoxin | 5 | October 20, 2011 |
| vancomycin side effects and adr | 13 | October 20, 2011 |
| vancomycin toxicity | 6 | October 20, 2011 |
| protein binding, metabolism, elimination | 6 | October 19, 2011 |
| vancomycin DISTRIBUTION | 9 | October 19, 2011 |
| vancomycin: appropriate or inappropriate use | 17 | October 19, 2011 |
| vancomycin | 11 | October 19, 2011 |
| Drug interactions: signs and symptoms | 17 | October 9, 2011 |
| contraindications for DM | 34 | October 1, 2011 |
| Diabetes Meds | 10 | October 1, 2011 |
| VTE | 28 | October 1, 2011 |
| ag 3 continued 2 | 28 | September 22, 2011 |
| ag 3 continued | 19 | September 22, 2011 |
| Specific Differences and advantages | 10 | September 22, 2011 |
| ag 3 | 24 | September 22, 2011 |
| hyperlipidemia | 5 | September 9, 2011 |
| deremer | 18 | September 1, 2011 |
| vesicants/pulmonary, hypersensitivity, mucositis | 28 | August 31, 2011 |
| nephrotoxicity, neuropathy | 23 | August 31, 2011 |
| Skin rash/hepatotoxicity | 14 | August 31, 2011 |
| chemotherapy induced NV; cardiotoxicity; alopecia, acral erythema | 25 | August 31, 2011 |
| toxicity assessment/chemotherapy induced N/V | 6 | August 31, 2011 |
| requirements of approval/efficacy assessment terminology | 9 | August 31, 2011 |
| requirements of approval/efficacy assessment terminology | 9 | August 31, 2011 |
| safety recommendations/catheters | 18 | August 30, 2011 |
| dosing (deremar) | 11 | August 30, 2011 |
| chemotherapy terminology (deremer) | 10 | August 30, 2011 |
| models of tumor growth/combination therapy | 11 | August 30, 2011 |
| cell cyle specificity | 18 | August 30, 2011 |
| chemo terms | 102 | August 30, 2011 |
| bisphosphanates | 42 | May 4, 2011 |
| format of clinical trial | 20 | April 7, 2011 |
| AED: metabolism | 10 | March 28, 2011 |
| AED: MOA | 15 | March 28, 2011 |
| AED: ADR | 26 | March 28, 2011 |
| AED: USES | 19 | March 28, 2011 |
| Risks | 26 | March 6, 2011 |
| hiv continued | 18 | March 4, 2011 |
| HIV | 14 | March 4, 2011 |
| HIV | 14 | March 4, 2011 |
| inhalation agents | 40 | March 3, 2011 |
| other ddrugs used for IV induction | 18 | March 3, 2011 |
| thiopental, etomidate, propofol | 26 | March 3, 2011 |
| OR drugs | 7 | March 3, 2011 |
| overweight and obesity | 29 | March 3, 2011 |
| schizophrenia | 15 | March 3, 2011 |
| side effects of atypical agents | 9 | March 3, 2011 |
| Autism | 12 | March 3, 2011 |
| SE: ritalin vs atomoxetine | 14 | March 3, 2011 |
| SE: ritalin vs atomoxetine | 14 | March 3, 2011 |
| inattention vs hyperactivity vs impulsivisity | 18 | March 3, 2011 |
| ADHD | 22 | March 3, 2011 |
| general anesthetics | 55 | February 28, 2011 |
| antipsychotics | 136 | February 28, 2011 |
| opioids | 144 | February 27, 2011 |
| gen anesthesia | 19 | February 27, 2011 |
| opioid receptors | 4 | February 24, 2011 |
| clinical use of antipsychotics | 4 | February 24, 2011 |
| pharmacologic effects of antipsychotics | 4 | February 24, 2011 |
| antipsychotics side effects | 6 | February 24, 2011 |
| receptor blocking specificity | 15 | February 24, 2011 |
| antipsychotic drugs listed | 22 | February 24, 2011 |
| major dopaminergic pathways | 12 | February 24, 2011 |
| drugs of abuse MOA | 56 | February 23, 2011 |
| class of abused drugs | 12 | February 23, 2011 |
| schedule of drugs | 21 | February 23, 2011 |
| drugs of abuse toxicity | 28 | February 23, 2011 |
| drugs of abuse | 19 | February 23, 2011 |
| tolerance, dependence, addiction | 50 | February 23, 2011 |
| mixed agonists (opioids) | 20 | February 22, 2011 |
| partial agonists (opioids) | 8 | February 22, 2011 |
| full agonists | 20 | February 22, 2011 |
| full, partial, mixed agoinsts (opioids) | 25 | February 22, 2011 |
| serotonin physiology | 9 | February 5, 2011 |
| Serotonin Receptor types | 27 | February 5, 2011 |
| serotonin intro | 14 | February 5, 2011 |
| H2 receptor antagonists | 3 | February 5, 2011 |
| H1 toxicity and drug interactions | 7 | February 5, 2011 |
| H1 antagonist clinical use | 13 | February 5, 2011 |
| H1 antagonists: pharmacodynamics | 14 | February 5, 2011 |
| H1 antagonists | 12 | February 5, 2011 |
| H1 vs H2 antagonists | 23 | February 5, 2011 |
| clinical use of histamine | 11 | February 5, 2011 |
| histamine Physiology | 7 | February 5, 2011 |
| histamine Physiology | 13 | February 5, 2011 |
| histamine receptors | 28 | February 5, 2011 |
| histamine intro | 9 | February 5, 2011 |
| azy | 34 | February 3, 2011 |
| trace elements | 21 | February 3, 2011 |
| anti-emetics | 77 | January 31, 2011 |
| migraine | 63 | January 31, 2011 |
| examples of antidepressants | 99 | January 31, 2011 |
| antidepressantd | 20 | January 31, 2011 |
| antihistamines | 84 | January 29, 2011 |
| diabetes | 5 | December 9, 2010 |
| drug induced hyperglycemia | 10 | December 9, 2010 |
| diabetes | 4 | December 9, 2010 |
| chronic stable angina: treatment | 38 | December 9, 2010 |
| risk factors | 22 | December 9, 2010 |
| clinical manifestations of atherosclerosis | 6 | December 9, 2010 |
| stable vs unstable | 11 | December 9, 2010 |
| increased vs decreased MVO2 | 6 | December 9, 2010 |
| ischemic heart disease | 24 | December 9, 2010 |
| disease 3 | 16 | December 9, 2010 |
| tx 2 | 14 | December 8, 2010 |
| disease 2 | 36 | December 8, 2010 |
| drug of choice | 14 | December 8, 2010 |
| disease | 38 | December 8, 2010 |
| structure | 12 | December 8, 2010 |
| acute otitis media | 3 | December 8, 2010 |
| cystitis | 11 | December 8, 2010 |
| yeast | 19 | December 8, 2010 |
| tests | 12 | December 8, 2010 |
| life threatening rashes | 34 | December 8, 2010 |
| more random | 15 | December 8, 2010 |
| treatments | 30 | December 8, 2010 |
| cases: | 22 | December 8, 2010 |
| meningitis | 17 | December 8, 2010 |
| random | 22 | December 8, 2010 |
| worms | 9 | December 8, 2010 |
| tx genital infections | 8 | December 8, 2010 |
| genital infections | 14 | December 8, 2010 |
| tuberculosis | 36 | December 8, 2010 |
| symptoms | 31 | December 8, 2010 |
| drugs | 10 | December 8, 2010 |
| tx with.... | 112 | December 7, 2010 |
| NSAIDs | 46 | December 7, 2010 |
| lipid lowering drugs | 37 | December 7, 2010 |
| eicosanoids | 49 | December 7, 2010 |
| NSAIDs | 45 | December 6, 2010 |
| gout | 63 | December 6, 2010 |
| prostaglandins: drugs | 21 | December 6, 2010 |
| prostaglandins: background | 51 | December 6, 2010 |
| cholinoceptor-activating drugs | 19 | December 5, 2010 |
| name the class 3 | 16 | December 5, 2010 |
| hypertension | 39 | December 4, 2010 |
| hyperlipidemia | 47 | December 4, 2010 |
| name the class (chapter 34) | 29 | December 4, 2010 |
| coagulation disorders | 4 | December 4, 2010 |
| name the class of drug | 23 | December 4, 2010 |
| heart failure | 32 | December 4, 2010 |
| Angina | 23 | December 4, 2010 |
| non-selective COX inhibitors | 70 | December 3, 2010 |
| NSAIDs | 39 | December 3, 2010 |
| bacteria 2 | 45 | November 28, 2010 |
| bacteria 2 | 45 | November 28, 2010 |
| gram positive vs. gram negative | 71 | November 28, 2010 |
| spanish | 20 | November 18, 2010 |
| agonists and antagonists | 21 | November 10, 2010 |
| propterites of vasoactive peptides | 30 | November 10, 2010 |
| vasodilator vs vasoconstrictor | 10 | November 10, 2010 |
| hypothyroidism and hyperthyroidism risks | 8 | November 7, 2010 |
| thyroid | 15 | November 7, 2010 |
| thyroid | 15 | November 7, 2010 |
| normal ranges thyroid | 6 | November 7, 2010 |
| Thyroid | 41 | November 7, 2010 |
| stroke | 40 | November 7, 2010 |
| lipids | 7 | November 7, 2010 |
| hypertension...TACKETT | 34 | November 6, 2010 |
| a | 23 | November 3, 2010 |
| alskdfjlaskdfj | 10 | November 3, 2010 |
| adsfadsfa | 17 | November 3, 2010 |
| asdf | 17 | November 3, 2010 |
| antiarr | 22 | November 3, 2010 |
| antiarrthymics | 82 | November 3, 2010 |
| ARB's | 47 | November 2, 2010 |
| Beta antagonists | 36 | November 2, 2010 |
| alpha antagonist | 37 | November 2, 2010 |
| random | 4 | November 2, 2010 |
| cardiac glycosides | 19 | November 2, 2010 |
| Anti-Angina | 68 | November 2, 2010 |
| ACE background | 44 | November 1, 2010 |
| asthma drugs | 35 | November 1, 2010 |
| mixture | 119 | October 27, 2010 |
| sulfonamides | 14 | October 27, 2010 |
| hepatitis/respiratory diseases | 32 | October 27, 2010 |
| antifungals | 61 | October 27, 2010 |
| TB drug therapies | 19 | October 27, 2010 |
| tetracycline | 14 | October 27, 2010 |
| clindamycin | 7 | October 27, 2010 |
| aminoglycosides | 37 | October 27, 2010 |
| chloramphenicol | 6 | October 27, 2010 |
| macrolides, azalides, ketolides | 34 | October 27, 2010 |
| streptogramins | 6 | October 27, 2010 |
| lipopeptides and bacitracin | 25 | October 27, 2010 |
| B-lactams--Penicillins | 60 | October 26, 2010 |
| misc synthetic antibacterials | 31 | October 26, 2010 |
| quinolones | 27 | October 26, 2010 |
| bacterial media | 66 | October 25, 2010 |
| heart failure key concepts | 11 | October 17, 2010 |
| drug induced pulmonary disease | 30 | October 16, 2010 |
| emphysema vs. chronic bronchitis | 22 | October 16, 2010 |
| pulmonary function testing | 10 | October 16, 2010 |
| drug categories and drugs which may induce nasal disease | 7 | October 16, 2010 |
| cobb | 26 | October 16, 2010 |
| ch 8 drugs | 21 | October 11, 2010 |
| ch 7 drugs | 23 | October 11, 2010 |
| drugs used for heart failure: cardiac glycosides, diuretics, aldosterone antagonists, ace inhibitors, arbs, beta 1 agonists, beta blockers, phosphodiesterase inhibitors, vasodilators | 55 | October 11, 2010 |
| drugs used for angina pectoris: nitrates, beta blockers or calcium channel blockers? | 26 | October 11, 2010 |
| alpha blockers or beta blockers? | 34 | October 11, 2010 |
| alpha or beta? | 39 | October 11, 2010 |
| ch 13 drugs | 23 | October 11, 2010 |
| ch 12 drugs | 21 | October 11, 2010 |
| ch 10 drugs | 34 | October 11, 2010 |
| ch 9 drugs | 42 | October 11, 2010 |
| drugs of Chapter 7: cholinoceptor-activating and cholinesterase-inhibiting drugs | 9 | October 10, 2010 |
| drugs from chapter 6--intro to autonomic pharmacology | 24 | October 10, 2010 |
| end of adrenergics | 18 | October 7, 2010 |
| adrenergic bronchodilators | 28 | October 7, 2010 |
| adrenergic agents intro | 18 | October 7, 2010 |
| neuromuscular blocking agents | 37 | October 7, 2010 |
| the rest of anticholinergics | 21 | October 7, 2010 |
| anticholinergics (overactive bladder) | 29 | October 7, 2010 |
| anticholinergics introduction | 42 | October 7, 2010 |
| ANS--cholinergic reversible inhibitors med chem | 83 | October 7, 2010 |
| properties of solutions | 33 | October 4, 2010 |
| distribution phenomena | 12 | October 4, 2010 |
| buffers | 10 | October 4, 2010 |
| ionization I | 22 | October 4, 2010 |
| dissolution rate | 20 | October 4, 2010 |
| dissolution rate | 20 | October 4, 2010 |
| solubility | 35 | October 4, 2010 |
| solutions | 15 | October 4, 2010 |
| table 6-2 | 24 | September 29, 2010 |
| table 6-3 sympathetic | 22 | September 29, 2010 |
| infectious pg 20-23 | 17 | September 23, 2010 |
| infectious test 1 | 2 | September 22, 2010 |
| gram (-) spirochetes | 29 | September 22, 2010 |
| gram (-) sprirochetes: syphilis | 8 | September 22, 2010 |
| Misc. Gram (-) other enterobacteriacea | 37 | September 22, 2010 |
| Escherichia | 18 | September 22, 2010 |
| Salmonella | 13 | September 22, 2010 |
| Enterobacteriaccae | 7 | September 22, 2010 |
| neisseria | 10 | September 22, 2010 |
| Bacterial Cell morphology | 20 | September 20, 2010 |
| disease and infectious agent | 11 | September 20, 2010 |
| gout key concepts | 7 | September 19, 2010 |
| Osteoarthritis key concepts | 10 | September 19, 2010 |
| lab values | 12 | September 19, 2010 |
| 1st set | 49 | September 19, 2010 |
| pregnancy classes | 9 | September 19, 2010 |
| autoimmune inner ear disease | 29 | September 19, 2010 |
| vertigo | 27 | September 19, 2010 |
| differentiation of sensorineural and conductive deafness | 14 | September 19, 2010 |
| selected products for external otitis | 16 | September 19, 2010 |
| products for external ear and drum | 9 | September 19, 2010 |
| external ear | 7 | September 19, 2010 |
| dr cobbs study sheet | 21 | September 18, 2010 |
| treating pain side effects | 66 | September 18, 2010 |
| pain | 20 | September 18, 2010 |
| adverse effects | 35 | September 16, 2010 |
| doses | 17 | September 16, 2010 |
| indications | 26 | September 16, 2010 |
| diuretics | 25 | September 16, 2010 |
| drug card 2- brand/generic | 17 | September 16, 2010 |
| diuretics | 25 | September 16, 2010 |
| diuretics: drugs | 16 | September 12, 2010 |
| Ch 3 terms-- pharmacology | 10 | September 11, 2010 |
| Ch 2 Terms--pharmacology | 18 | September 10, 2010 |
| functional groups | 36 | September 7, 2010 |
| metabolism (med chem) | 16 | September 6, 2010 |
| distribution (Med Chem) | 22 | September 6, 2010 |
| med chem: absorption | 20 | September 6, 2010 |
| Isozymes | 25 | September 6, 2010 |
| med chem 3 | 18 | September 4, 2010 |
| med chem 2 | 17 | September 4, 2010 |
| med chem | 18 | September 4, 2010 |
| 1- dosing | 15 | September 2, 2010 |
| 1- pt counseling | 32 | September 2, 2010 |
| 1- adverse effects | 45 | September 2, 2010 |
| 1- indications | 15 | September 2, 2010 |
| 1- brand/generic | 15 | September 2, 2010 |
| methods for determining particle size | 41 | August 26, 2010 |
| gas, liquid, solid | 13 | August 25, 2010 |
| thermodynamics notes | 35 | August 25, 2010 |
| solid state notes | 66 | August 25, 2010 |
| topoisomerase | 18 | April 7, 2010 |
| targets!!! | 7 | April 7, 2010 |
| antibodies | 43 | April 7, 2010 |
| pharmacogenomic | 24 | April 7, 2010 |
| Compounds for Biochem | 42 | April 7, 2010 |
| managed care | 9 | April 6, 2010 |
| four phases of evolution of health services | 35 | April 6, 2010 |
| history of hospital pharmacy | 6 | April 5, 2010 |
| hc training | 9 | April 5, 2010 |
| 1st,2nd,3rd,4th tier | 21 | April 5, 2010 |
| Professions w/ Prescribing Authority in GA | 35 | April 5, 2010 |
| Pharmacist Prescribing | 20 | April 5, 2010 |
| marfan syndrome | 26 | April 1, 2010 |
| counseling points | 60 | April 1, 2010 |
| beta blockers, etc 2 | 30 | April 1, 2010 |
| betablocker, etc | 21 | April 1, 2010 |
| brand/generic | 35 | April 1, 2010 |
| clinical apps | 68 | April 1, 2010 |
| alterations of pulmonary fxn | 78 | March 15, 2010 |
| pulmonary physiology | 89 | March 15, 2010 |
| respiratory system | 74 | March 15, 2010 |
| alterations of pulmonary fxn | 56 | March 12, 2010 |
| pl lab | 7 | March 2, 2010 |
| additional RNA molecules found in Eukaryotes | 5 | February 3, 2010 |
| anatomy 2 prelab 1 quiz | 46 | January 13, 2010 |
| hypothalamci hormones | 10 | December 7, 2009 |
| seriously the rest of notes | 26 | December 7, 2009 |
| seriously the rest of notes | 15 | December 7, 2009 |
| rest of notes | 29 | December 7, 2009 |
| effects | 8 | December 7, 2009 |
| target of pituitary hormones | 8 | December 7, 2009 |
| anterior and posterior pituitary hormones | 10 | December 7, 2009 |
| hypothalamic and pituitary hormones | 4 | December 7, 2009 |
| necrosis vs apoptosis | 30 | December 5, 2009 |
| hypogonadism | 16 | December 4, 2009 |
| erectile dysfunction | 12 | December 4, 2009 |
| male and female sexual dysfunction | 18 | December 4, 2009 |
| pharmacology | 28 | November 11, 2009 |
| drug card test 3-brand generic | 15 | November 10, 2009 |
| Treatment of Seizures | 12 | November 4, 2009 |
| Characteristics of seizures | 27 | November 4, 2009 |
| seizures: old terminology--> new | 6 | November 4, 2009 |
| epilepsy | 17 | November 4, 2009 |
| cerebellum: peduncles | 6 | November 3, 2009 |
| cerebellum: 3 parts | 26 | November 3, 2009 |
| reprod: obstetric terms | 37 | November 1, 2009 |
| reprod: gynecologic terms | 47 | November 1, 2009 |
| reprod: female anatomic terms | 12 | November 1, 2009 |
| reprod: diagnostic tests and procedures | 9 | November 1, 2009 |
| reprod: symptomatic and diagnostic terms | 10 | November 1, 2009 |
| helpful prefixes | 24 | October 31, 2009 |
| diagnostics | 8 | October 31, 2009 |
| symptomatic terms | 36 | October 31, 2009 |
| body movements | 13 | October 31, 2009 |
| anatomic terms; joints and muscles | 9 | October 31, 2009 |
| musculoskeletal system terminology | 90 | October 31, 2009 |
| Reproductive System | 115 | October 31, 2009 |
| motor nerve tracts | 25 | October 21, 2009 |
| 3 steps to voluntary movement | 11 | October 21, 2009 |
| integration of nervous system cont'd | 13 | October 21, 2009 |
| sensory and association areas of the cerebral cortex | 11 | October 21, 2009 |
| sensory nerve tracts | 37 | October 21, 2009 |
| responses of sensory receptors | 12 | October 21, 2009 |
| sensory nerve endings in skin | 30 | October 21, 2009 |
| 1: types of sensory receptors | 20 | October 21, 2009 |
| sensation | 14 | October 21, 2009 |
| autonomic nervous system disorders | 25 | October 19, 2009 |
| effects of drugs | 10 | October 19, 2009 |
| receptors and neurotransmitters | 33 | October 19, 2009 |
| functional generalizations of ans | 13 | October 19, 2009 |
| somatic vs autonomic | 15 | October 18, 2009 |
| general mechanisms that evoke headache | 73 | October 18, 2009 |
| headache | 9 | October 18, 2009 |
| thermoregulation cont'd | 43 | October 18, 2009 |
| fever | 28 | October 18, 2009 |
| regulation of thermal environment | 29 | October 18, 2009 |
| thermoregulation | 31 | October 18, 2009 |
| pain | 37 | October 17, 2009 |
| alpha ketoglutarate dehydrogenase complex | 4 | October 15, 2009 |
| The Citric Acid Cycle | 5 | October 15, 2009 |
| diseases associated with glycogen | 14 | October 14, 2009 |
| receptor to brain | 9 | October 12, 2009 |
| receptors | 22 | October 12, 2009 |
| how we register sensations | 8 | October 12, 2009 |
| prelab quiz | 6 | October 12, 2009 |
| non invasive tests | 24 | October 6, 2009 |
| CSF | 34 | October 6, 2009 |
| invasive diagnostic tests for brain and spinal cord | 24 | October 6, 2009 |
| cranial nerve disorders | 13 | October 6, 2009 |
| spinal cord syndromes associated with incomplete transection | 13 | October 6, 2009 |
| spinal cord syndromes associated with incomplete transection | 13 | October 5, 2009 |
| autonomic hyperreflexia | 19 | October 5, 2009 |
| common sites of spinal cord injury | 8 | October 5, 2009 |
| spinal shock | 9 | October 5, 2009 |
| head injury | 15 | October 5, 2009 |
| clinical manifestations of increased intracranial pressure | 7 | October 5, 2009 |
| cushihng's response to head injury | 3 | October 5, 2009 |
| intracranial pressure (ICP) associated with head injury | 8 | October 5, 2009 |
| brain injury | 42 | October 5, 2009 |
| neuroex: clinical testing of cranial nerve function | 18 | October 4, 2009 |
| neuroex: cerebral functions and deficits | 28 | October 4, 2009 |
| neuroexamination | 5 | October 4, 2009 |
| subdisciplines | 18 | October 2, 2009 |
| diagnostic aids | 25 | October 2, 2009 |
| effects of alcohol on the chronic drinker | 5 | October 2, 2009 |
| BAL % | 8 | October 2, 2009 |
| BAL | 8 | October 1, 2009 |
| diagnostic aids | 25 | October 1, 2009 |
| medical records | 144 | October 1, 2009 |
| intro to pharm | 62 | October 1, 2009 |
| questions from the back | 7 | September 28, 2009 |
| nerve fiber types | 12 | September 28, 2009 |
| PNS disorders | 10 | September 28, 2009 |
| skin of lumbosacral plexuses | 4 | September 28, 2009 |
| different plexuses | 5 | September 28, 2009 |
| lumbosacral plexus | 14 | September 28, 2009 |
| skin | 5 | September 28, 2009 |
| bracial nerves | 15 | September 28, 2009 |
| quiz 4 | 10 | September 28, 2009 |
| diencephalon | 10 | September 28, 2009 |
| cerebellum | 8 | September 28, 2009 |
| cerebellum | 8 | September 28, 2009 |
| cerebellum | 13 | September 27, 2009 |
| brain | 57 | September 27, 2009 |
| enzymes | 21 | September 24, 2009 |
| biochem test 2 | 78 | September 24, 2009 |
| activator/inhibitor | 11 | September 24, 2009 |
| problem drug cards | 47 | September 22, 2009 |
| pharmacology | 57 | September 22, 2009 |
| drug cards | 148 | September 22, 2009 |
| skeletal system | 51 | September 21, 2009 |
| primary sources | 40 | September 19, 2009 |
| secondary sources | 30 | September 19, 2009 |
| tertiary sources contd | 50 | September 19, 2009 |
| Tertiary Sources | 22 | September 19, 2009 |
| indications of drugs | 38 | September 17, 2009 |
| heat production/ abnormal contractions | 9 | September 16, 2009 |
| types of fatigue | 7 | September 16, 2009 |
| types of muscle tissue | 16 | September 15, 2009 |
| muscle physiology vocabulary | 12 | September 15, 2009 |
| muscle physiology I | 78 | September 15, 2009 |
| veins and arteries quiz | 61 | September 13, 2009 |
| brand/generic drug card test 1 | 75 | September 12, 2009 |
| cell death | 51 | September 9, 2009 |
| manifestations of cellular injury | 27 | September 9, 2009 |
| cellular injury | 34 | September 9, 2009 |
| cellular adaptation | 34 | September 9, 2009 |
| cell and tissue death | 18 | September 9, 2009 |
| genetics and disease | 53 | September 9, 2009 |
| staging of metastases | 14 | September 9, 2009 |
| biology of cancer | 74 | September 8, 2009 |
| nomenclature of cancer | 8 | September 8, 2009 |
| vitamin functions, etc | 27 | May 4, 2009 |
| vitamin-coenzyme | 14 | May 4, 2009 |
| vitamin-B? | 5 | May 4, 2009 |
| vitamins-disease | 14 | May 4, 2009 |
| terms for ecology lab quiz | 21 | April 22, 2009 |
| Ecology lab | 10 | April 22, 2009 |
| chapter 14 | 26 | April 14, 2009 |
| Chapter 13 | 6 | April 14, 2009 |
| Chapter 15 | 14 | April 14, 2009 |
| ecology 17 | 8 | April 14, 2009 |
| ecology 16 | 32 | April 14, 2009 |
| Chapter 8 Terms | 31 | March 18, 2009 |
| Chapter 7 terms | 48 | March 18, 2009 |
| Ecology: Chapter 6 Terms | 49 | March 18, 2009 |
| more biochem | 104 | February 5, 2009 |
| pages 1-13 | 42 | February 2, 2009 |
| Amino Acids | 23 | February 2, 2009 |
| classes | 99 | December 8, 2008 |
| 4th drug card | 99 | December 8, 2008 |
| intro to pharm | 120 | December 8, 2008 |